|
|
|
|
What's new in PMS?
PMS has been a legitimate diagnosis for several decades, but there are no FDA-approved therapies for it. Off-label use of medications that are FDA-approved for PMDD is common in clinical practice. For patients taking daily SSRIs for anxiety or mood symptoms, premenstrual dose adjustment offers a novel management strategy.
|
| |
More>>
|
|
|
|
|
|
What's the best approach to spontaneous premature ovarian failure?
Learning that she has what used to be called premature menopause can devastate a woman in her 20s or 30s. Diagnose this mysterious condition without delay, deliver the bad news in person, and provide sensitive answers to four basic questions.
|
| |
More>>
|
|
|
|
|
|
A pharmacotherapeutic review of treatment options for infertility in women
The growing trend for women to wait later in life before having their first child has placed many women at a higher risk for difficult conception. Medications chosen for a patient will vary depending on the identified cause of the infertility. Additionally, economic factors will play a role.
|
| |
More>>
|
|
|
|
|
|
Is it umbilical cord prolapse?
Being familiar with the risk factors that predispose a patient to cord prolapse is the first step toward preventing the complication. Recognizing the early warning signs is the first step toward averting a life-threatening disaster.
|
| |
More>>
|
|
|